Q1 2026 Psychedelic Drug Development Pipeline: Bullseye Charts By Watertime - February 19, 2026 12 Q1 2026 BULLSEYE CHARTS This resource is supported by Learn More UBC partners with biopharma to modernize evidence… Source RELATED ARTICLESMORE FROM AUTHOR Five Phases, Eight Circuits: Chinese Medicine as a Map for Psychedelic Consciousness Rachel Turetzky, PhD & Douglas S. Wingate, DTCM: The Eight-Circuit Model, Metaprogramming, and Psychedelic Therapy Pα+ Psychedelic Bulletin #228: Inside the Lilly-Atai Deal; An Update on the GH-AtaiBeckley Patent Standoff; Field Reacts to FDA’s Guidance; Resilient Readies Resubmission
